However, when stratified by PSA level, there were no significant differences in cancer detection rate between the TR and TP groups for patients with 20–100 ng/mL PSA level (72.6 vs 64.6%, p = 0.280) in our study, which may be caused by the small sample size in the subgroup. This evidence concerns the gene KLK3 and cancer.